SKYE vs. CD

Last updated Jun 25, 2026

SKYE (Skye Bioscience, Inc) and CD (Chaince Digital Holdings Inc) are both stocks. SKYE operates in Biotechnology (Healthcare), while CD operates in Capital Markets (Financial Services). Over the past 10 years, SKYE returned -41.66%/yr vs -24.90%/yr for CD. At a 0.05 correlation, their price movements are largely independent.

Performance

SKYE vs. CD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Skye Bioscience, Inc (SKYE) and Chaince Digital Holdings Inc (CD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SKYE achieves a -9.43% return, which is significantly lower than CD's -4.83% return. Over the past 10 years, SKYE has underperformed CD with an annualized return of -41.66%, while CD has yielded a comparatively higher -24.90% annualized return.

SKYE

• 1D: -3.00%
• 1M: -18.12%
• YTD: -9.43%
• 6M: -18.62%
• 1Y: -81.24%
• 3Y*: -50.94%
• 5Y*: -55.75%
• 10Y*: -41.66%

CD

• 1D: 1.07%
• 1M: -35.99%
• YTD: -4.83%
• 6M: -21.56%
• 1Y: 21.91%
• 3Y*: 28.10%
• 5Y*: -4.79%
• 10Y*: -24.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SKYE vs. CD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SKYE Skye Bioscience, Inc	-9.43%	-73.51%	4.04%	-32.84%	-68.85%	30.00%	-69.47%	-67.25%	163.16%	-49.67%
CD Chaince Digital Holdings Inc	-4.83%	-27.23%	162.69%	109.41%	-64.75%	3.93%	85.98%	17.14%	-93.14%	-72.87%

Correlation

The correlation between SKYE and CD is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.03
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Apr 8, 2015	0.05

Fundamentals

EPS SKYE : -$1.45 CD : -$0.23
Total Revenue (TTM) SKYE : $0.00 CD : $1.67M
Gross Profit (TTM) SKYE : -$180.01K CD : -$1.10M
EBITDA (TTM) SKYE : $10.92M CD : -$10.65M

Return for Risk

SKYE vs. CD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SKYE

SKYE Risk / Return Rank: 10
SKYE Sharpe Ratio Rank: 11
SKYE Sortino Ratio Rank: 10
SKYE Omega Ratio Rank: 9
SKYE Calmar Ratio Rank: 6
SKYE Martin Ratio Rank: 16

CD

CD Risk / Return Rank: 58
CD Sharpe Ratio Rank: 48
CD Sortino Ratio Rank: 71
CD Omega Ratio Rank: 71
CD Calmar Ratio Rank: 50
CD Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SKYE vs. CD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Skye Bioscience, Inc (SKYE) and Chaince Digital Holdings Inc (CD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SKYE	CD	Difference
Sharpe ratio: Return per unit of total volatility	-0.76	0.12	-0.88
Sortino ratio: Return per unit of downside risk	-1.16	1.64	-2.80
Omega ratio: Gain probability vs. loss probability	0.84	1.22	-0.37
Calmar ratio: Return relative to maximum drawdown	-0.93	0.24	-1.17
Martin ratio: Return relative to average drawdown	-1.19	0.32	-1.51

SKYE vs. CD - Sharpe Ratio Comparison

The current SKYE Sharpe Ratio is -0.76, which is lower than the CD Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of SKYE and CD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SKYE vs. CD - Drawdown Comparison

The maximum SKYE drawdown since its inception was -99.96%, roughly equal to the maximum CD drawdown of -99.79%. Use the drawdown chart below to compare losses from any high point for SKYE and CD.

Drawdown Indicators

	SKYE	CD	Difference
Max Drawdown Largest peak-to-trough decline	-99.96%	-99.79%	-0.17%
Max Drawdown (1Y) Largest decline over 1 year	-87.85%	-89.83%	+1.98%
Max Drawdown (3Y) Largest decline over 3 years	-96.79%	-89.83%	-6.96%
Max Drawdown (5Y) Largest decline over 5 years	-98.66%	-90.81%	-7.85%
Max Drawdown (10Y) Largest decline over 10 years	-99.83%	-99.58%	-0.25%
Current Drawdown Current decline from peak	-99.95%	-98.22%	-1.73%
Average Drawdown Average peak-to-trough decline	-94.94%	-90.02%	-4.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	68.06%	68.77%	-0.71%

Volatility

SKYE vs. CD - Volatility Comparison

The current volatility for Skye Bioscience, Inc (SKYE) is 18.63%, while Chaince Digital Holdings Inc (CD) has a volatility of 36.89%. This indicates that SKYE experiences smaller price fluctuations and is considered to be less risky than CD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SKYE	CD	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.63%	36.89%	-18.26%
Volatility (6M) Calculated over the trailing 6-month period	61.13%	104.41%	-43.28%
Volatility (1Y) Calculated over the trailing 1-year period	109.99%	186.64%	-76.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	130.80%	151.90%	-21.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	136.71%	146.03%	-9.32%

Dividends

SKYE vs. CD - Dividend Comparison

Neither SKYE nor CD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both SKYE and CD in my portfolio?

SKYE and CD have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SKYE or CD?

CD has higher volatility (36.89%) compared to SKYE (18.63%). In terms of maximum drawdown, SKYE dropped -99.96% vs CD's -99.79%.

Which has better risk-adjusted returns?

CD currently has the higher Sharpe Ratio (0.12 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.